3 Broker Favorite Biopharmas Your Portfolio Must Have Post author:Sam Post published:January 17, 2018 Post category:BioPharma These stocks have been given a Strong Buy or Buy rating by 80% or more brokers. Source: BioSpace You Might Also Like Suitors Weigh Bids for Sanofi's $3B European Generics Biz January 10, 2018 Biogen Poaches Merck Exec to Lead New Marketing Team November 2, 2017 Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS December 28, 2017
